Newsbenzinga
Positive FDA Decision Propels Rebranded Filana Therapeutics Epilepsy Research Forward
· Published
Article summary
The FDA lifted a clinical hold on Filana Therapeutics' IND application, allowing a Phase 2a trial for a TSC-related epilepsy treatment.
An excerpt from the original article.
Comments —
Loading comments…